James Orrell
Plus aucun poste en cours
Profil
Dr. James Orrell is Vice President-Finance & Administration at Seahorse Bioscience, Inc.
Dr. Orrell was previously employed as a Principal by FLIR Systems, Inc.
He received his undergraduate degree from Linfield College, a graduate degree from Portland State University, and a doctorate degree from the University of Washington.
Anciens postes connus de James Orrell
| Sociétés | Poste | Fin |
|---|---|---|
| TELEDYNE FLIR, LLC | Corporate Officer/Principal | - |
Seahorse Bioscience, Inc.
 Seahorse Bioscience, Inc. Medical SpecialtiesHealth Technology Seahorse Bioscience, Inc. provides metabolic analyzers and stress kits. Its medical device is use to determine a new therapeutic approach in treating acute myeloid leukemia. The company was founded on November 2, 2000 and is headquartered in Billerica, MA. | Fondateur | - |
Formation de James Orrell
| University of Washington | Doctorate Degree |
| Linfield College | Undergraduate Degree |
| Portland State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Teledyne FLIR LLC
 Teledyne FLIR LLC Telecommunications EquipmentElectronic Technology Teledyne FLIR LLC engages in the development of technologies that enhance perception and awareness. It designs, develops, markets, and distributes solutions that detect people, objects and substances that may not be perceived by human senses. Its products include thermal imaging, visible-light imaging, video analytics, measurement and diagnostic, and advanced threat detection systems. The company was founded in 1978 and is headquartered in Wilsonville, OR. | Electronic Technology |
Seahorse Bioscience, Inc.
Seahorse Bioscience, Inc. Medical SpecialtiesHealth Technology Seahorse Bioscience, Inc. provides metabolic analyzers and stress kits. Its medical device is use to determine a new therapeutic approach in treating acute myeloid leukemia. The company was founded on November 2, 2000 and is headquartered in Billerica, MA. | Health Technology |